Hantavirus (HV)
infection, which underlies hantavirus
hemorrhagic fever with renal syndrome and
hantavirus pulmonary syndrome, remains to be a severe clinical challenge. Here, we synthesized small interfering RNAs (siRNAs) that target the encoding sequences of HV strain 76-118, and validated their inhibitory role in virus replication in HV-infected monkey kidney Vero E6 cells. A chimeric
protein, 3G1-Cκ-tP, consisting of a single-chain
antibody fragment (3G1) against the HV surface envelop
glycoprotein, the constant region of human
immunoglobulin κ chain (Cκ), and truncated
protamine (
amino acids 8-29, tP), was further generated. The fusion
protein showed high affinity to HV
antigen on the infected cell membrane, and internalized through
clathrin-mediated endocytosis; it bound to siRNAs via the basic
nucleic acid-rich
protamine fragment, leading to their specific delivery into HV-infected cells and efficient inhibition of virus replication. An
encephalitis mouse model was established via intracranial HV administration.
Intraperitoneal injection of siRNAs complexed with 3G1-Cκ-tP achieved specific distribution of siRNAs in HV-infected brain cells, significantly reduced HV
antigen levels, and effective protection from HV
infection-derived animal death. These results provide a compelling rationale for novel therapeutic protocols designed for HV
infection and related disorders.